£95.74

It has never been this cheap. We have no record of a lower price.

£96 today · cheaper than every other day in the last 3 months

Springer Migraine and Headache Disorders: Global Perspective - SDG3

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 46 days · 46 data points (no recent data)

Historical
Generating forecast…
£95.74 £90.95 £92.87 £94.78 £96.70 £98.61 £100.53 11 August 2026 22 August 2026 02 September 2026 13 September 2026 25 September 2026
View at Amazon ↗

Price data last checked 45 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 46 days • 1 price levels

Days at Price
46 days 0 12 23 35 46 £96 Days at Price

Price Analysis

Most common price: £96 (46 days, 100.0%)

Price range: £96 - £96

Price levels: 1 different prices over 46 days

Description

This pioneering book from Springer addresses the critical intersection of migraine management and sustainable development, focusing on SDG3's goal of ensuring healthy lives and promoting well-being for all. Migraine remains a neglected disorder despite its prevalence and debilitating impact on individuals worldwide, yet it plays a significant role in achieving global health objectives. The book unravels the complexities surrounding migraine within the context of sustainable development, offering a unique contribution to the medical and healthcare literature. It provides essential insights for healthcare practitioners, neurologists, and policymakers seeking to understand and address migraine as a public health priority that affects populations across all ages and demographics.

Key Features

Springer's comprehensive examination of migraine and headache disorders within the framework of the Sustainable Development Goals.

Addresses SDG3 objectives by exploring how migraine prevention and treatment contribute to ensuring healthy lives and well-being for all ages.

Designed for internal medicine practitioners and clinical neurophysiology specialists seeking evidence-based perspectives on migraine management.

Bridges the gap between neurology research and global health policy by presenting migraine as a critical public health concern.

Offers unique insights into the debilitating impact of migraine on individuals and communities worldwide.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
07 February 2026
Listed Since
13 November 2025

Barcode

No barcode data available

Similar Products You Might Like

Clinical Scales for Headache Disorders
98% match

Clinical Scales for Headache Disorders

Springer

£95.74 19 Sep 2026
Management of Migraine Pain: Emerging Opportunities and Challenges
98% match

Management of Migraine Pain: Emerging Opportunities and Challenges

Springer

£162.90 02 Oct 2026
Interventional Management of Migraines and Headache Disorders Book
98% match

Interventional Management of Migraines and Headache Disorders Book

Elsevier

£119.49 02 Oct 2026
Headache Disorders in Pandemic Conditions
98% match

Headache Disorders in Pandemic Conditions

Springer

£95.74 19 Sep 2026
Headache Disorders in Pandemic Conditions
98% match

Headache Disorders in Pandemic Conditions

Springer

£73.11 18 Sep 2026
Neuroimaging of Headache Disorders
98% match

Neuroimaging of Headache Disorders

Springer

£101.05 18 Sep 2026
The Biochemistry of Migraine
98% match

The Biochemistry of Migraine

Springer

£158.11 19 Sep 2026
Headache and Comorbidities in Childhood and Adolescence
98% match

Headache and Comorbidities in Childhood and Adolescence

Springer

£80.65 17 Sep 2026
Comorbid Conditions in the Treatment of Headache
98% match

Comorbid Conditions in the Treatment of Headache

CRC Press

£75.11 11 Sep 2026
Migraine, Words and Fiction
98% match

Migraine, Words and Fiction

Cambridge Scholars Publishing

£67.99 23 Sep 2026
Interventional Management of Headache Pain
97% match

Interventional Management of Headache Pain

Elsevier

£147.99 19 Sep 2026
Migraine
97% match

Migraine

IntechOpen

£118.98 12 Sep 2026
Monoclonal Antibodies in Headache: From Bench to Patient
97% match

Monoclonal Antibodies in Headache: From Bench to Patient

Springer

£71.84 22 Sep 2026
Anti-Migraine Drugs in India Outlook 2023-2028 Study
97% match

Anti-Migraine Drugs in India Outlook 2023-2028 Study

£515.00 24 Aug 2026
US Anti-Migraine Drug Market Outlook 2023-2028 Study
97% match

US Anti-Migraine Drug Market Outlook 2023-2028 Study

£520.00 07 Nov 2026
Traitements de crise et traitements de fond de la migraine: Aspects pharmacothérapeutiques (Omn.Univ.Europ.)
97% match

Traitements de crise et traitements de fond de la migraine: Aspects pharmacothérapeutiques (Omn.Univ.Europ.)

OmniScriptum

£70.00 30 Sep 2026
Diagnosis and Management of Head and Face Pain: A Practical Approach
97% match

Diagnosis and Management of Head and Face Pain: A Practical Approach

Springer

£91.67 02 Oct 2026
Anti-Migraine Drug Outlook Latin America 2016-2021 Study
97% match

Anti-Migraine Drug Outlook Latin America 2016-2021 Study

£425.00 07 Nov 2026
US Anti-Migraine Drug Market Outlook 2016-2021 Study
97% match

US Anti-Migraine Drug Market Outlook 2016-2021 Study

£595.00 06 Nov 2026
Anti-Migraine Drug Outlook in Greater China 2016-2021
97% match

Anti-Migraine Drug Outlook in Greater China 2016-2021

£595.00 25 Aug 2026
Headache: Evaluation and Management
97% match

Headache: Evaluation and Management

Foster Academics

£71.12 18 Sep 2026
The 2021-2026 World Outlook for Anti-Migraine Drugs
97% match

The 2021-2026 World Outlook for Anti-Migraine Drugs

£795.00 24 Aug 2026
Anti-Migraine Drug Outlook in Asia 2016-2021 Study
97% match

Anti-Migraine Drug Outlook in Asia 2016-2021 Study

£425.00 06 Nov 2026
Anti-Migraine Drugs in Europe Outlook 2016-2021 Report
97% match

Anti-Migraine Drugs in Europe Outlook 2016-2021 Report

£425.00 24 Aug 2026